Patent Medicine Market Size, Segments, and Growth Forecast by 2031

Coverage: Patent Medicine Market covers analysis By Medicine Type (Solid Drug Products, Semi-Solid Drug Products, Liquid Drug Products, Gas/Aerosols Drug Products, Others); Indication (Cardiovascular Disease, Respiratory Disease, Immunological Disease, Blood Disease, Gastrointestinal Disease, Ophthalmic Disease, Orthopedic Disease, Neurodegenerative Disease, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00017480
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Patent Medicine Market is expected to register a CAGR of 5.9% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.

The research report on the Patent Medicine Market is segmented by type into OTC medicines, herbal and natural remedies, and prescription medications. Applications analyzed include pain relief, cough and cold treatment, digestive health, and skin care treatments. End-users include pharmaceutical companies, retail pharmacies, healthcare providers, and e-commerce platforms. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses. This report provides insights into the increasing demand for over-the-counter medications, the rise of natural patent medicines, and trends in self-medication globally.

Purpose of the Report

The report Patent Medicine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Patent Medicine Market Segmentation

Medicine Type
  • Solid Drug Products
  • Semi-Solid Drug Products
  • Liquid Drug Products
  • Gas/Aerosols Drug Products
Indication
  • Cardiovascular Disease
  • Respiratory Disease
  • Immunological Disease
  • Blood Disease
  • Gastrointestinal Disease
  • Ophthalmic Disease
  • Orthopedic Disease
  • Neurodegenerative Disease

Strategic Insights

Patent Medicine Market Growth Drivers
  • Increasing Self-medication Trends: The Patent Medicine Market experiences substantial growth because more people are choosing to self-medicate. As people become more aware of their health today they prefer to address minor health issues themselves instead of seeing a doctor. The popularity of self-medication practices has resulted in increased consumer demand for OTC medicines which consumers can easily find in pharmacies as well as supermarkets and online retailers. People frequently choose patent medicines because manufacturers advertise them as delivering rapid relief for typical conditions like headaches and colds along with digestive problems and mild pain. In developed economies where health consciousness runs high consumers tend to manage minor health problems themselves instead of seeking doctor consultations. The continuous increase in healthcare expenses makes self-medication more attractive to consumers. The financial pressures of doctor appointments and prescription drugs push many people towards over-the-counter patent medicines which increases their demand. Consumers find these products appealing because they can easily buy them from multiple outlets like physical stores and online platforms for fast access to treatments. The market size for patent medicines should grow alongside the rising trend of self-medication because consumers are choosing cost-effective and accessible non-prescription treatments which will expand market share.
  • Rising Health Awareness and Preventive Healthcare: The global escalation in health awareness is prompting consumers to take an active role in managing their health. The Patent Medicine Market benefits from the rising emphasis on preventive healthcare practices. Consumers today turn to patent medicines both as treatments and preventive measures since they prefer addressing common health issues early before they turn into severe conditions. People are using patent medicines more frequently to treat mild digestive problems and early flu symptoms along with occasional headaches because these individuals focus on health maintenance. Investing in preventive healthcare lowers future medical expenses while improving general health which increases the attractiveness of patent medicines. Developed countries experience growing medication demands because aging populations require treatments for chronic issues like pain and cardiovascular problems. Health-focused patent medicines that boost immunity or improve digestive health now match consumer wellness trends as preventive care becomes more popular. As more people choose preventive health solutions over reactive medical treatments the market share for patent medicines will increase. Healthcare systems are shifting towards prevention which will enlarge market dimensions for preventive medicines and enable companies to develop innovations to meet this demand.
  • Expansion of Online Retail Channels: The Patent Medicine Market has expanded significantly due to e-commerce growth which allows consumers to conveniently access over-the-counter medications online. The development of online pharmacies and health stores has transformed how people buy their medicines since consumers can now shop from their homes. This trend enables consumers to access an extensive range of products while comparing prices and reading consumer reviews alongside its convenience. Patients living in rural or remote areas can now access necessary medications through online stores without the need to travel to distant physical outlets. The emergence of mobile health apps and telehealth services leads more consumers to seek self-medication advice and recommendations through digital platforms which drives online demand for patent medicines. Online retail allows customers to conveniently locate and purchase patent medicines for conditions such as pain, cough and cold, digestive problems which leads to growth in market size and patent medicine market share. The rise of digital health platforms enables pharmaceutical companies and retailers to enhance their online visibility while developing customized marketing approaches to reach wider consumer demographics. The movement to online sales provides pharmaceutical companies with a chance to establish deeper connections with customers which enhances trust and strengthens brand loyalty despite market competition.
Patent Medicine Market Future Trends
  • Personalized and Tailored Medicine: In the Patent Medicine Market one emerging trend shows a move towards personalized medicine. Developments in genetic research and health data analytics alongside technological progress are driving the trend toward producing medications customized for individual health requirements. Customized treatments tailored to individual needs have become increasingly popular which has fueled significant growth in this trend. When considering patent medicines personalized solutions should consist of products designed to treat particular health conditions more efficiently by considering individual genetic profiles alongside their lifestyle choices and existing health conditions. Manufacturers have the chance to satisfy increasing consumer demands for targeted treatments by developing pain relief products that are customized for people who have particular allergies or sensitivities. The research of pharmacogenomics which examines genetic impacts on drug responses drives this transition toward precision medicine within the patent medicine industry. By using a personalized approach for patent medicines patients get products that match their specific traits which leads to improved treatment results. Tailored solutions development enhances patient satisfaction while simultaneously establishing market competitiveness for companies in the sector. The Patent Medicine Market will see market share expansion as personalized medicine advances since development of customized products increases and consumers require more individualized healthcare solutions.
  • Focus on Packaging and Convenience: A major trend in the Patent Medicine Market involves packaging innovation as pharmaceutical companies work to create products that prioritize convenience and consumer-friendliness. Consumers with hectic schedules now require medication packaging solutions that prioritize simplicity along with portability and efficiency. Pharmaceutical companies are rolling out user-friendly packaging options which include single-dose packets along with childproof caps and portable formats designed for mobility. These packaging solutions provide convenience for consumers while simultaneously helping patients follow their medication instructions by simplifying the medication intake process. Consumers now see sustainable packaging as a key factor because they are more aware of their environmental footprint. Businesses are using sustainable materials and reducing packaging waste to meet consumer demand for environmentally friendly products. In markets where self-medication trends continue to rise consumers prioritize medications that integrate smoothly into their everyday schedules because of the convenience factor. Businesses which develop packaging solutions that combine practicality with environmental sustainability stand to achieve market dominance over their competitors. The market size for patent medicines will enlarge as more consumers choose practical and eco-friendly solutions which will promote industry growth through this trend.
  • Increased Regulation and Compliance: The Patent Medicine Market is experiencing a major trend of stricter regulatory oversight. Health authorities and governments worldwide are implementing more detailed regulations to make sure over-the-counter products adhere to strict safety, quality, and efficacy standards. Regulations govern several aspects such as product labeling requirements and ingredient disclosures along with manufacturing process standards. Businesses operating in the patent medicine sector need to comply with these regulations to guarantee their products are both safe and reliable. To meet rising transparency requirements organizations are now focusing on giving consumers detailed information about patent medicine ingredients as well as their side effects and dosage instructions. Pharmaceutical companies are emphasizing compliance with local and international standards as they evolve because this adherence now serves as a market differentiator. Organizations focused on regulatory compliance can avoid potential legal liabilities while building stronger trust from their customer base. The development of quality-certified patent medicines which meet safety standards is predicted to be driven by this emerging trend. Market consolidation will occur because the focus on regulatory compliance allows well-established companies to dominate since they can handle complex regulations. This development trend will cause the Patent Medicine Market to experience growth and increased expansion overall.
Patent Medicine Market Opportunities
  • Rising Demand for Convenience and Accessibility: Modern consumers value convenience and accessibility more than ever before which opens new opportunities in the Patent Medicine Market to distribute products that are both easy to use and readily available. Current consumers want medication options that integrate smoothly into their hectic schedules through single-dose packaging solutions that are portable and available online. Instant relief OTC patent medicines for minor health problems such as pain, colds, and digestive troubles see higher demand because self-medication practices become more common. Through digital channels like e-commerce platforms and mobile health applications combined with online pharmacies businesses can extend their reach to remote areas that lack physical pharmacy infrastructure. Patent medicine companies can find growth potential by creating digital-first solutions that respond to modern consumers’ needs in this market transformation that prioritizes convenience. Some digital-first solutions for patent medicine companies encompass portable packaging options together with subscription services and customized health advice utilizing digital health information. Patent medicine companies that focus on digital retail solutions and improve consumer digital interactions will likely achieve a competitive edge and expand their market share because more people are choosing digital platforms to meet their healthcare needs.
  • Increasing Focus on Preventive Healthcare: The Patent Medicine Market stands to gain from the global healthcare shift towards preventive care which presents notable possibilities for market alignment. Consumers today show more awareness about keeping healthy and taking steps to stop illnesses before they develop. There is an escalating consumer requirement for preventive patent medicines that both treat minor health issues and enhance general health. The popularity of products that support immune health and digestive health along with pain management solutions is increasing because consumers want to prevent major health problems. Businesses which develop natural patent medicines that prevent health problems will successfully reach this expanding market. The growing interest of health-conscious consumers in wellness products gives companies a chance to develop innovative product solutions which meet holistic health demands. The market size for patent medicines with a preventive focus will expand greatly as preventive care becomes more integrated into mainstream healthcare systems through which market share will increase. Companies can establish themselves as preventive health leaders by offering effective products and educating consumers about prevention benefits which aligns with proactive health management trends.
  • Innovation in Product Formulations and Delivery Methods: The Patent Medicine Market benefits from innovation in product formulations and delivery methods because consumers demand solutions that provide better symptom relief and health management. Consumers increasingly prefer topical and transdermal drugs because they deliver prompt relief for pain and inflammation as well as other common conditions. Sprays and gels along with liquid formulations are becoming more popular because they are easy to use and non-invasive. Manufacturers have a chance to develop targeted solutions because personalized medicine attracts growing interest which leads consumers to prefer products that include natural or organic ingredients or address specific health conditions. Controlled-release and extended-release technologies deliver extended periods of relief for consumers which leads to better patient satisfaction and treatment adherence. Development of combination therapies that use multiple active ingredients to address multiple symptoms at once may lead to new product introductions in the market. Pharmaceutical companies can achieve significant market expansion by developing products that provide relief for multiple symptoms at once. Manufacturers who prioritize innovative formulations and advanced delivery technologies will take market leadership as demand for efficient and convenient delivery methods keeps increasing.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Patent Medicine Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Patent Medicine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Patent Medicine Market?

The Patent Medicine Market is expected to register a CAGR of 5.9% from 2025-2031.

What are the driving factors impacting the Patent Medicine Market?

The major driving factors supporting the Patent Medicine Market growth are- Increasing Self-medication Trends, Rising Health Awareness and Preventive Healthcare, Expansion of Online Retail Channels.

What are the future trends in the Patent Medicine Market?

Key Future Trends in the Patent Medicine Market are- Personalized and Tailored Medicine, Focus on Packaging and Convenience, and Increased Regulation and Compliance.

Which are the key players in the Patent Medicine Market?

Key companies in Patent Medicine Market are - Pfizer Inc.Otsuka Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Roche Holding AG, Amgen Inc., AbbVie Inc., Sanofi

What are the deliverable formats of the Patent Medicine Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Patent Medicine Market - By Medicine Type
1.3.2 Patent Medicine Market - By Indication
1.3.3 Patent Medicine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PATENT MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.3. EXPERT OPINIONS
5. PATENT MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PATENT MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PATENT MEDICINE - GLOBAL MARKET OVERVIEW
6.2. PATENT MEDICINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PATENT MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 - MEDICINE TYPE
7.1. OVERVIEW
7.2. MEDICINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. SOLID DRUG PRODUCTS
7.3.1. Overview
7.3.2. Solid Drug Products Market Forecast and Analysis
7.4. SEMI-SOLID DRUG PRODUCTS
7.4.1. Overview
7.4.2. Semi-Solid Drug Products Market Forecast and Analysis
7.5. LIQUID DRUG PRODUCTS
7.5.1. Overview
7.5.2. Liquid Drug Products Market Forecast and Analysis
7.6. GAS/AEROSOLS DRUG PRODUCTS
7.6.1. Overview
7.6.2. Gas/Aerosols Drug Products Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. PATENT MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASE
8.3.1. Overview
8.3.2. Cardiovascular Disease Market Forecast and Analysis
8.4. RESPIRATORY DISEASE
8.4.1. Overview
8.4.2. Respiratory Disease Market Forecast and Analysis
8.5. IMMUNOLOGICAL DISEASE
8.5.1. Overview
8.5.2. Immunological Disease Market Forecast and Analysis
8.6. BLOOD DISEASE
8.6.1. Overview
8.6.2. Blood Disease Market Forecast and Analysis
8.7. GASTROINTESTINAL DISEASE
8.7.1. Overview
8.7.2. Gastrointestinal Disease Market Forecast and Analysis
8.8. OPHTHALMIC DISEASE
8.8.1. Overview
8.8.2. Ophthalmic Disease Market Forecast and Analysis
8.9. ORTHOPEDIC DISEASE
8.9.1. Overview
8.9.2. Orthopedic Disease Market Forecast and Analysis
8.10. NEURODEGENERATIVE DISEASE
8.10.1. Overview
8.10.2. Neurodegenerative Disease Market Forecast and Analysis
8.11. OTHERS
8.11.1. Overview
8.11.2. Others Market Forecast and Analysis
9. PATENT MEDICINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PATENT MEDICINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PATENT MEDICINE MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. OTSUKA PHARMACEUTICAL CO., LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ROCHE HOLDING AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AMGEN INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ABBVIE INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRISTOL-MYERS SQUIBB COMPANY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Otsuka Pharmaceutical Co., Ltd.
3. GlaxoSmithKline plc
4. Novartis AG
5. Merck & Co., Inc.
6. Roche Holding AG
7. Amgen Inc.
8. AbbVie Inc.
9. Sanofi
10. Bristol-Myers Squibb Company

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..